bioRxivCell Biology
Nuclear poly-glutamine aggregates rupture the nuclear envelope and hinder its repair
G. Korsten, R. A. Pelle, B. Hoogenberg, H. H. Kampinga, L. C. Kapitein
Abstract
Huntingtons disease (HD) is caused by a poly-glutamine expansion of the huntingtin protein, resulting in the formation of poly-glutamine aggregates. The mechanisms of toxicity that result in the complex HD pathology remain only partially understood. Here we show that nuclear polyglutamine aggregates deform the nuclear envelope (NE) and induce NE ruptures that are often repaired incompletely. These ruptures coincide with deformations of the nuclear lamina and lead to lamina scar formation. Expansion microscopy enabled resolving the ultrastructure of nuclear aggregates and revealed polyglutamine fibrils sticking into the cytosol at rupture sites, suggesting a mechanism for incomplete repair. These findings implicate nuclear polyQ aggregate-induced loss of NE integrity as a potential contributing factor to Huntingtons disease and other polyglutamine diseases. One-sentence summaryAggregates associated with Huntingtons Disease induce ruptures of the nuclear envelop that compromise its barrier function
- organism: human
- assay: imaging
- research focus: cell signaling & trafficking
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fragile polyQ assemblies cause Golgipathy in Huntington's disease
Lixiang Ma, Xinyu Chen, … Hexige Saiyin·bioRxiv·Oct 6, 2024
- PolyQ expansion does not alter the Huntingtin-HAP40 complex
B. Huang, Q. Guo, … R. Fernandez-Busnadiego·bioRxiv·Feb 2, 2021
- Autophagy preferentially degrades non-fibrillar polyQ aggregates
D. Y. Zhao, F. J. Bauerlein, … F. Wilfling·bioRxiv·Aug 8, 2023
- Tadpole-like conformations of huntingtin exon 1 with expanded polyglutamine engenders novel interactions in cells
E. A. Newcombe, K. M. Ruff, … D. M. Hatters·bioRxiv·Aug 22, 2017
- Identification of novel therapeutic targets for polyglutamine toxicity disorders that target mitochondrial fragmentation
Annika Traa, Emily Machiela, … Jeremy M. Van Raamsdonk·bioRxiv·Oct 19, 2021
- The structure of pathogenic huntingtin exon-1 defines the bases of its aggregation propensity
C. A. Elena-Real, A. Sagar, … P. Bernado·bioRxiv·Oct 25, 2022